ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$194.65−5.86 (-2.92%)
Close on Nov 13, 2026Market cap $14.90BP/E 33.5Yield –
ICON ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
ICON's ebitda for the twelve months ending Sep 30, 2026 was $1.08B, up 13.5% year over year. For fiscal 2025 it was $825.84M, down 45.7% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $1.52B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $825.84M | -45.7% |
| FY2024 | Dec 31, 2024 | $1.52B | +2.0% |
| FY2023 | Dec 31, 2023 | $1.49B | +9.2% |
| FY2022 | Dec 31, 2022 | $1.36B | +96.8% |
| FY2021 | Dec 31, 2021 | $693.52M | +51.5% |
| FY2020 | Dec 31, 2020 | $457.63M | -7.5% |
| FY2019 | Dec 31, 2019 | $494.96M | +12.7% |
| FY2018 | Dec 31, 2018 | $439.27M | +9.9% |
| FY2017 | Dec 31, 2017 | $399.64M | +7.6% |
| FY2016 | Dec 31, 2016 | $371.27M | +9.5% |
| FY2015 | Dec 31, 2015 | $339.21M | +33.1% |
| FY2014 | Dec 31, 2014 | $254.89M | +52.0% |
| FY2013 | Dec 31, 2013 | $167.68M | +51.3% |
| FY2012 | Dec 31, 2012 | $110.84M | +62.7% |
| FY2011 | Dec 31, 2011 | $68.13M | -45.9% |
| FY2010 | Dec 31, 2010 | $125.97M | -10.1% |
| FY2009 | Dec 31, 2009 | $140.11M | +10.1% |
| FY2008 | Dec 31, 2008 | $127.23M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $293.26M | – |
| Q2 FY2026 | Jun 30, 2026 | $228.60M | -30.4% |
| Q1 FY2026 | Mar 31, 2026 | $264.07M | -18.2% |
| Q4 FY2025 | Dec 31, 2025 | $298.14M | -30.2% |
| Q3 FY2025 | Sep 30, 2025 | -$123.88M | -131.3% |
| Q2 FY2025 | Jun 30, 2025 | $328.66M | +7.2% |
| Q1 FY2025 | Mar 31, 2025 | $322.93M | -17.5% |
| Q4 FY2024 | Dec 31, 2024 | $427.05M | +8.6% |
| Q3 FY2024 | Sep 30, 2024 | $395.60M | -0.8% |
| Q2 FY2024 | Jun 30, 2024 | $306.60M | -11.3% |
| Q1 FY2024 | Mar 31, 2024 | $391.63M | +11.0% |
| Q4 FY2023 | Dec 31, 2023 | $393.27M | +13.8% |
| Q3 FY2023 | Sep 30, 2023 | $398.95M | +3.5% |
| Q2 FY2023 | Jun 30, 2023 | $345.63M | +7.4% |
| Q1 FY2023 | Mar 31, 2023 | $352.77M | +13.2% |
| Q4 FY2022 | Dec 31, 2022 | $345.59M | +21.6% |
| Q3 FY2022 | Sep 30, 2022 | $385.61M | +164.6% |
| Q2 FY2022 | Jun 30, 2022 | $321.81M | +147.3% |
| Q1 FY2022 | Mar 31, 2022 | $311.74M | +129.5% |
| Q4 FY2021 | Dec 31, 2021 | $284.21M | +107.4% |
| Q3 FY2021 | Sep 30, 2021 | $145.74M | +16.4% |
| Q2 FY2021 | Jun 30, 2021 | $130.15M | +78.8% |
| Q1 FY2021 | Mar 31, 2021 | $135.85M | +10.8% |
| Q4 FY2020 | Dec 31, 2020 | $137.00M | +4.6% |
| Q3 FY2020 | Sep 30, 2020 | $125.20M | +0.0% |
| Q2 FY2020 | Jun 30, 2020 | $72.81M | -40.0% |
| Q1 FY2020 | Mar 31, 2020 | $122.61M | +4.4% |
| Q4 FY2019 | Dec 31, 2019 | $131.03M | +12.3% |
| Q3 FY2019 | Sep 30, 2019 | $125.20M | +8.9% |
| Q2 FY2019 | Jun 30, 2019 | $121.28M | +22.6% |
| Q1 FY2019 | Mar 31, 2019 | $117.44M | +8.1% |
| Q4 FY2018 | Dec 31, 2018 | $116.70M | +10.2% |
| Q3 FY2018 | Sep 30, 2018 | $115.00M | +13.6% |
| Q2 FY2018 | Jun 30, 2018 | $98.96M | +7.1% |
| Q1 FY2018 | Mar 31, 2018 | $108.62M | +8.5% |
| Q4 FY2017 | Dec 31, 2017 | $105.92M | +5.8% |
| Q3 FY2017 | Sep 30, 2017 | $101.22M | – |
| Q2 FY2017 | Jun 30, 2017 | $92.39M | – |
| Q1 FY2017 | Mar 31, 2017 | $100.11M | – |
| Q4 FY2016 | Dec 31, 2016 | $100.10M | – |
See a number that looks wrong?